Bioxydyn is a specialist imaging CRO that provides advanced MRI services for the pharmaceutical, academic, and medical devices sectors.
Bioxydyn is a specialist imaging CRO that provides advanced MRI services for the pharmaceutical, academic, and medical devices sectors.
We support all stages of the deployment of MRI in clinical trials, specialising in quantitative MRI biomarkers that provide safe and non-invasive insight into disease progression and drug response. We generate robust pharmacodynamic measurements of tissue and organ function across a wide range of disease areas. Our validated biomarkers deliver repeatable, high-quality data, enabling rich, specific insights from smaller patient populations.
With decades of experience and operational excellence, we deliver rigorous and efficient studies backed by industry-leading expertise.
Read moreFrom study design to database lock, Bioxydyn offers one integrated solution.
We design endpoints, documentation & MR protocols aligned to your objectives.
We harmonise scanners, train site teams quickly and qualify your sites.
Sites upload imaging data securely via VoxelFlow with real-time tracking of submissions across all sites.
We rapidly review every dataset against specifications, providing clear and timely feedback to keep your study on track.
We run validated analysis pipelines with full auditability.
We deliver decision-ready outputs in your preferred data format. We archive documentation and data.
Bioxydyn offers imaging biomarkers for respiratory diseases such as cystic fibrosis, asthma, pulmonary hypertension, interstitial disease and COPD. We have extensive expertise in quantitative MRI methods for assessing regional lung function, including measurements of ventilation and perfusion.
Read moreBioxydyn provides advanced functional MRI biomarkers in oncology, using techniques such as diffusion MRI and dynamic contrast-enhanced (DCE) MRI, and is the leading CRO offering tumor hypoxia imaging to inform therapy effectiveness or characterise tumour physiology.
Read moreBioxydyn has delivered multiple studies for pharmaceutical companies using quantitative imaging of inflammation in a wide range of diseases, including functional imaging of joints in rheumatoid arthritis and osteoarthritis and renal imaging in nephritis.
Read moreBioxydyn is experienced in the deployment of quantitative MRI methods for neuroscience in conditions including multiple sclerosis, neurodevelopmental conditions, dementia and neuro-oncology. Our collaboration with Queen Square Analytics enables advanced AI methods for patient stratification with a focus on multiple sclerosis and Alzheimer's disease.
Read moreBioxydyn offers MRI measurement of liver transporter fluxes using dynamic contrast-enhanced MRI (DCE-MRI), plus other imaging biomarkers, including relaxation time measurements, in the investigation of liver diseases.
Read moreMost successful drug developments involve a careful balance between safety and efficacy. Imaging biomarkers of drug safety have played a major role in avoiding drug-induced harm to many important organ systems, including liver, lung, brain, heart, and the musculoskeletal system.
Read moreFrom study design to database lock, Bioxydyn offers one integrated solution.
We design endpoints, documentation & MR protocols aligned to your objectives.
We harmonise scanners, train site teams quickly and qualify your sites.
Sites upload imaging data securely via VoxelFlow, our validated platform, with real-time tracking of submissions across all sites.
We rapidly review every dataset against protocol specifications, providing clear and timely feedback to keep your study on track.
We run validated analysis pipelines with full auditability.
We deliver decision-ready outputs with transparent documentation.
